Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

NCT07090044 is registered in ClinicalTrials.gov with Retina Research Institute, LLC as lead sponsor.

NCT NCT07090044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period
Lead sponsor
Retina Research Institute, LLC
Phase
Phase 4
Overall status
Completed
Start date
August 20, 2021
Completion date
December 8, 2022
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy, macular degeneration choroidal neovascularization, macular edema, vein occlusion